✦ LIBER ✦

Lymphomatoid papulosis in a patient with Crohn's disease treated with infliximab

✍ Scribed by William Outlaw; Alan Fleischer; Richard Bloomfeld

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 105 KB
Volume: 15
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe Listeria meningoencephalitis in a

Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease

✍ Ferenc Izbéki; Ferenc Nagy; Zoltán Szepes; Ildikó Kiss; János Lonovics; Tamás Mo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Systemic amyloidosis with Crohn's diseas

Systemic amyloidosis with Crohn's disease treated with infliximab

✍ Yoon Kyung Park; Dong Soo Han; Chang Soo Eun 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Occurrence of hepatoxicicty and elevated

Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab

✍ B. Moum; Z. Konopski; K.F. Tufteland; J. Jahnsen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Salmonella septic arthritis in a patient

Salmonella septic arthritis in a patient with Crohn's disease on infliximab

✍ Jean Y. Rim; Allan R. Tenorio 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

The use of tumor necrosis factor a (TNFa) inhibitors such as infliximab, etanercept, and adalimumab for various autoimmune diseases, including Crohn's disease (CD) and ulcerative colitis (UC), has increased in the past few years. While associated with symptomatic relief in many patients, the use of

Cancer in Crohn's Disease patients treat

Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study

✍ Livia Biancone; Carmelina Petruzziello; Ambrogio Orlando; Anna Kohn; Sandro Ardi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 2 views

## Background: The long-term risk of neoplasia in Crohn's disease (CD) patients treated with infliximab is undefined. The aim was to assess, in a multicenter, matched-pair study, whether infliximab use in CD is associated with an increased frequency of neoplasia in the long term. Methods: A multic

Splenic function and IgM-memory B cells

Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab

✍ Antonio Di Sabatino; M. Manuela Rosado; Paolo Cazzola; Paolo Biancheri; Francesc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB 👁 1 views

Background: Under experimental chronic inflammation, tumor necrosis factor (TNF)-␣ plays a role in damaging spleen marginal zone. This latter has a crucial function in mounting B cell-dependent immune responses against infections by encapsulated bacteria. In Crohn's disease (CD), a chronic inflammat